3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Terminated
1
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
6
Sarcoma
3
Plasma cell
2
Other hematologic neoplasm
2
Lymphoid
2
Dermatologic
2
Thoracic
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Endocrine
1
CNS
1
Conditions
Brain Neoplasms
362
Glioblastoma
299
Glioma
239
Neuroblastoma
95
Neoplasms
70
Central Nervous System Neoplasms
62
Astrocytoma
61
Meningioma
59
Breast Neoplasms
51
Lung Neoplasms
46
Carcinoma, Non-Small-Cell Lung
46
Melanoma
40
Sarcoma
35
Medulloblastoma
33
Meningeal Carcinomatosis
32
Recurrence
31
Neoplasm Metastasis
28
Diffuse Intrinsic Pontine Glioma
28
Prostatic Neoplasms
27
Pheochromocytoma
26
Paraganglioma
26
Neurofibromatosis 1
26
Pancreatic Neoplasms
24
Ovarian Neoplasms
24
Oligodendroglioma
22
Ependymoma
21
Osteosarcoma
20
Head and Neck Neoplasms
20
Spinal Cord Neoplasms
19
Kidney Neoplasms
19
Interventions
cobimetinib
1
Vemurafenib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Erdheim-Chester Disease
×
CNS
×
Clear all
NCT05768178
2025-11-24
DETERMINE
Cancer Research UK
Phase 2/3
Recruiting
30 enrolled